Scandinavian Biopharma Completes Successful Pediatric Phase IIb ETVAX® Trial in The Gambia
Gambiaj.com – (BANJUL, The Gambia) – Scandinavian Biopharma has announced the successful completion of its Phase IIb pediatric trial for ETVAX®, a groundbreaking vaccine candidate aimed at combating enterotoxigenic Escherichia coli (ETEC), commonly referred to as traveler’s diarrhea. The trial, which was conducted in The Gambia